Inhaled Ciclesonide for Patients With Asthma or Chronic Obstructive Pulmonary Disease and COVID-19-Reply
Errataetall: |
CommentOn: JAMA Intern Med. 2022 Jan 1;182(1):42-49. - PMID 34807241 |
---|---|
Medienart: |
E-Artikel |
Erscheinungsjahr: |
2022 |
---|---|
Erschienen: |
2022 |
Enthalten in: |
Zur Gesamtaufnahme - volume:182 |
---|---|
Enthalten in: |
JAMA internal medicine - 182(2022), 5 vom: 01. Mai, Seite 572 |
Sprache: |
Englisch |
---|
Beteiligte Personen: |
Clemency, Brian M [VerfasserIn] |
---|
Links: |
---|
Themen: |
---|
Anmerkungen: |
Date Completed 04.05.2022 Date Revised 12.05.2022 published: Print CommentOn: JAMA Intern Med. 2022 Jan 1;182(1):42-49. - PMID 34807241 Citation Status MEDLINE |
---|
doi: |
10.1001/jamainternmed.2022.0210 |
---|
funding: |
|
---|---|
Förderinstitution / Projekttitel: |
|
PPN (Katalog-ID): |
NLM338424164 |
---|
LEADER | 01000naa a22002652 4500 | ||
---|---|---|---|
001 | NLM338424164 | ||
003 | DE-627 | ||
005 | 20231226000638.0 | ||
007 | cr uuu---uuuuu | ||
008 | 231226s2022 xx |||||o 00| ||eng c | ||
024 | 7 | |a 10.1001/jamainternmed.2022.0210 |2 doi | |
028 | 5 | 2 | |a pubmed24n1128.xml |
035 | |a (DE-627)NLM338424164 | ||
035 | |a (NLM)35311914 | ||
040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
041 | |a eng | ||
100 | 1 | |a Clemency, Brian M |e verfasserin |4 aut | |
245 | 1 | 0 | |a Inhaled Ciclesonide for Patients With Asthma or Chronic Obstructive Pulmonary Disease and COVID-19-Reply |
264 | 1 | |c 2022 | |
336 | |a Text |b txt |2 rdacontent | ||
337 | |a ƒaComputermedien |b c |2 rdamedia | ||
338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
500 | |a Date Completed 04.05.2022 | ||
500 | |a Date Revised 12.05.2022 | ||
500 | |a published: Print | ||
500 | |a CommentOn: JAMA Intern Med. 2022 Jan 1;182(1):42-49. - PMID 34807241 | ||
500 | |a Citation Status MEDLINE | ||
650 | 4 | |a Journal Article | |
650 | 4 | |a Comment | |
650 | 7 | |a Pregnenediones |2 NLM | |
650 | 7 | |a ciclesonide |2 NLM | |
650 | 7 | |a S59502J185 |2 NLM | |
700 | 1 | |a Koster, David J |e verfasserin |4 aut | |
700 | 1 | |a Blaiss, Michael S |e verfasserin |4 aut | |
773 | 0 | 8 | |i Enthalten in |t JAMA internal medicine |d 2013 |g 182(2022), 5 vom: 01. Mai, Seite 572 |w (DE-627)NLM220635021 |x 2168-6114 |7 nnns |
773 | 1 | 8 | |g volume:182 |g year:2022 |g number:5 |g day:01 |g month:05 |g pages:572 |
856 | 4 | 0 | |u http://dx.doi.org/10.1001/jamainternmed.2022.0210 |3 Volltext |
912 | |a GBV_USEFLAG_A | ||
912 | |a GBV_NLM | ||
951 | |a AR | ||
952 | |d 182 |j 2022 |e 5 |b 01 |c 05 |h 572 |